Fludarabine, High Dose Cytarabine and Idarubicin-Based Induction Is Highly Effective in Young AML Patients with Concomitant NPM1 and FLT3-ITD Mutation Irrespectively of FLT3-ITD Allelic Burden

被引：0

作者：

Minetto, Paola ^{[1
]}

Candoni, Anna ^{[2
]}

Guolo, Fabio ^{[1
]}

Clavio, Marino ^{[1
]}

Zannier, Maria Elena ^{[3
]}

Miglino, Maurizio ^{[1
]}

Dubbini, Maria Vittoria ^{[4
]}

Carminati, Enrico

Sicuranza, Anna ^{[5
]}

Ciofini, Sara ^{[5
]}

Tedone, Elisabetta ^{[6
]}

Colombo, Nicoletta ^{[6
]}

Pugliese, Girolamo ^{[1
]}

Marcolin, Riccardo ^{[1
]}

Ballerini, Filippo ^{[1
]}

Cea, Michele ^{[1
]}

Gobbi, Marco

Bocchia, Monica ^{[7
]}

Fanin, Renato ^{[4
]}

Lemoli, Roberto Massimo ^{[1
]}

机构：

[1] IRCCS Osped Policlin San Martino, Dept Internal Med DiMI, Clin Hematol, Genoa, Italy

[2] Azienda Sanit Integrata Udine, Hematol, Udine, Italy

[3] Azienda Sanit Univ Integrata Udine, Div Hematol & Bone Marrow Transplantat, Udine, Italy

[4] Univ Udine, Div Hematol & BMT, Dept Med Area, Udine, Italy

[5] Univ Siena, Azienda Osped Univ Senese, Hematol, Siena, Italy

[6] IRCCS Osped Policlin San Martino, Clin Flow Cytometry Unit, Genoa, Italy

[7] Univ Siena, Hematol, Siena, Italy

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-131303

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3828

引用

页数：5

共 50 条

[1] Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3-ITD in NPM1 Mutated AML, Irrespectively of FLT3-ITD Allelic Burden
Minetto, Paola
Candoni, Anna
Guolo, Fabio
Clavio, Marino
Zannier, Maria Elena
Miglino, Maurizio
Dubbini, Maria Vittoria
Carminati, Enrico
Sicuranza, Anna
Ciofini, Sara
Colombo, Nicoletta
Pugliese, Girolamo
Marcolin, Riccardo
Santoni, Adele
Ballerini, Filippo
Lanino, Luca
Cea, Michele
Gobbi, Marco
Bocchia, Monica
Fanin, Renato
Lemoli, Roberto Massimo
CANCERS, 2021, 13 (01) : 1 - 13
[2] Intensive Fludarabine, High Dose Cytarabine and Idarubicin-Based Induction for Younger NPM1-Mutated AML Patient: Overcoming the Negative Prognosis of FLT3-ITD Mutation
Minetto, Paola
Candoni, Anna
Guolo, Fabio
Clavio, Marino
Zannier, Maria Elena
Miglino, Maurizio
Dubbini, Maria Vittoria
Sicuranza, Anna
Ciofini, Sara
Tedone, Elisabetta
Colombo, Nicoletta
Pugliese, Girolamo
Ballerini, Filippo
Cea, Michele
Bocchia, Monica
Fanin, Renato
Lemoli, Roberto Massimo
BLOOD, 2020, 136
[3] The FLT3-ITD Allelic Ratio and NPM1 Mutation Do Not Impact Outcomes in AML Patients with FLT3-ITD after Allo-HSCT: A Retrospective Propensity-Score Matching Study
Zhou, Cuiyan
Zheng, Fengmei
Xu, Lanping
Zhang, Xiaohui
Chang, Yingjun
Mo, Xiao-Dong
Sun, Yuqian
Wang, Yu
Huang, Xiao-Jun
BLOOD, 2022, 140 : 7689 - 7690
[4] A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed acute myeloid leukaemia
Ostronoff, Fabiana
Othus, Megan
Kantarjian, Hagop M.
Meshinchi, Soheil
Ravandi, Farhad
Hendrie, Paul C.
Faderl, Stefan
Becker, Pamela S.
Cortes, Jorge E.
Pagel, John M.
Petersdorf, Stephen H.
Godwin, John E.
Willman, Cheryl L.
Pierce, Sherry A.
List, Alan F.
Sandhu, Ravinder K.
Walter, Roland B.
Stirewalt, Derek L.
Appelbaum, Frederick R.
Estey, Elihu H.
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (01) : 130 - 132
[5] Simultaneous Detection of FLT3-ITD, FLT3-D835 and NPM1 Mutations in AML
Bernardino, L. P.
Nagy, P. L.
Hensel, J. W.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 578 - 578
[6] ADVERSE PROGNOSIS OF LOW AR FLT3-ITD IN AML AND CLINICAL BENEFIT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN AML PATIENTS WITH LOW AR FLT3-ITD AND NPM1
Kim, Hyeoung-Joon
Kim, TaeHyung
Kook, Hoon
Song, Ga-Young
Ahn, Seo-Yeon
Jung, Sung-Hoon
Kim, Mihee
Yang, Deok-Hwan
Lee, Je-Jung
Choi, Seung Hyun
Kim, Mi Yeon
Jung, Chul Won
Jang, Jun-Ho
Kim, Hee Je
Moon, Joon Ho
Sohn, Sang Kyun
Won, Jong-Ho
Park, Seong-Kyu
Kim, Sung-Hyun
Zhang, Zhaolei
Ahn, Jae-Sook
Kim, Dennis Dong Hwan
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 172 - 173
[7] Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia
Sakaguchi, Masahiro
Yamaguchi, Hiroki
Najima, Yuho
Usuki, Kensuke
Ueki, Toshimitsu
Oh, Iekuni
Mori, Sinichiro
Kawata, Eri
Uoshima, Nobuhiko
Kobayashi, Yutaka
Kako, Shinichi
Tajika, Kenji
Gomi, Seiji
Shono, Katsuhiro
Kayamori, Kensuke
Hagihara, Masao
Kanda, Junya
Uchiyama, Hitoji
Kuroda, Junya
Uchida, Naoyuki
Kubota, Yasushi
Kimura, Shinya
Kurosawa, Saiko
Nakajima, Nana
Marumo, Atsushi
Omori, Ikuko
Fujiwara, Yusuke
Yui, Shunsuke
Wakita, Satoshi
Arai, Kunihito
Kitano, Tomoaki
Kakihana, Kazuhiko
Kanda, Yoshinobu
Ohashi, Kazuteru
Fukuda, Takahiro
Inokuchi, Koiti
BLOOD ADVANCES, 2018, 2 (20) : 2744 - 2754
[8] Study of HOTAIR LncRNA in AML patients in context to FLT3-ITD and NPM1 mutations status
Mona Salah
Hamdy Zawam
Neven Bahaa Fouad
Nohair Soliman
Fatma Abdel Wahab Abdel Maksoud
Egyptian Journal of Medical Human Genetics, 22
[9] Study of HOTAIR LncRNA in AML patients in context to FLT3-ITD and NPM1 mutations status
Salah, Mona
Zawam, Hamdy
Fouad, Neven Bahaa
Soliman, Nohair
Maksoud, Fatma Abdel Wahab Abdel
EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2021, 22 (01)
[10] FLUDARABINE-CONTAINING INDUCTION INCREASES MINIMAL RESIDUAL DISEASE CLEARENCE AND IMPROVES SURVIVAL IN AML PATIENTS WITH CONCOMITANT NPM1 AND FLT3-ITD MUTATIONS
Minetto, P.
Guolo, F.
Clavio, M.
Damiani, D.
Toffoletti, E.
Michelutti, A.
Simeone, E.
Giannoni, L.
Guardo, D.
Agnelli, J.
Colombo, N.
Grasso, R.
Ballerini, F.
Miglino, M.
Tiribelli, M.
Gobbi, M.
HAEMATOLOGICA, 2015, 100 : 142 - 143

← 1 2 3 4 5 →